Source Post

SCHD Just Made a BIG Move — Here's What Changed

Sep 23, 2026

The creator discusses recent significant changes in the SCHD ETF's portfolio during its quarterly rebalancing. Key shifts include an increased exposure to the technology sector and a notable rise in semiconductor companies like Qualcomm and Texas Instruments to the top holdings. The creator also highlights the strong performance of stocks that SCHD increased its stake in, such as Merck, ConocoPhillips, and Abbott, questioning if the ETF's algorithm has a knack for timely exposure increases.

Linked Mentions

Tickers discussed in this post

MRVLNeutralLow ConvictionResearch Only

Marvell Technology is mentioned alongside AMD as a recent tech stock that could have provided significant gains if specific trading advice was followed.

NVDANeutralLow ConvictionResearch Only

Nvidia is mentioned as a contrast to Qualcomm's AI strategy, representing the cloud AI and GPU acceleration segment, which SCHD is not heavily exposed to.

PEPNeutralLow ConvictionResearch Only

PepsiCo's stock declined by about 7%, serving as an example of how some holdings adjusted by SCHD's rebalancing may not immediately perform well.

HDNeutralLow ConvictionResearch Only

Home Depot was a top 10 holding in SCHD before the rebalancing and remains a significant holding afterward.

UNHNeutralLow ConvictionResearch Only

UnitedHealth was a top 10 holding in SCHD before the rebalancing and remains a significant holding afterward.

PGNeutralLow ConvictionResearch Only

Procter & Gamble was a top 10 holding in SCHD before the rebalancing and remains a significant holding afterward.

CVXNeutralResearch Only

Chevron was listed as one of SCHD's top 10 holdings before the September 18th rebalance.

KONeutralResearch Only

Coca-Cola was mentioned as one of the top 10 holdings in SCHD prior to the September 18th rebalance.

AMGNNeutralMedium ConvictionSignal-backedSecondary

Amgen shares gained approximately 13% after SCHD increased its position during the recent quarterly rebalance.

BMYNeutralMedium ConvictionSignal-backedSecondary

Bristol Myers Squibb stock saw a 16% increase after SCHD adjusted its holdings in the latest quarterly rebalance.

Linked Signals

Tracked calls opened from this post

No linked signals were opened directly from this post.